Molecular Alterations of KIT Oncogene in Gliomas

Gliomas are the most common and devastating primary brain tumours. Despite therapeutic advances, the majority of gliomas do not respond either to chemo or radiotherapy. KIT, a class III receptor tyrosine kinase (RTK), is frequently involved in tumourigenic processes. Currently, KIT constitutes an at...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomes, Ana L., Reis-Filho, Jorge S., Lopes, José M., Martinho, Olga, Lambros, Maryou B. K., Martins, Albino, Schmitt, Fernando, Pardal, Fernando, Reis, Rui M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2007
Materias:
Other
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618227/
https://www.ncbi.nlm.nih.gov/pubmed/17726262
http://dx.doi.org/10.1155/2007/926274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618227/
https://www.ncbi.nlm.nih.gov/pubmed/17726262
http://dx.doi.org/10.1155/2007/926274

Ejemplares similares